Patient reported outcomes: past, present, and future by Jane A Scott
INVITED SPEAKER PRESENTATION Open Access
Patient reported outcomes: past, present, and
future
Jane A Scott
From Clinical Trials Methodology Conference 2011
Bristol, UK. 4-5 October 2011
For decades, clinical trials have relied on information
from patients about their symptoms, functioning, and
treatment experiences to evaluate treatment safety and
efficacy. Today, information reported directly by patients
(patient reported outcomes or “PROs”) using various
technologies serves as the primary source of data about
symptoms, functioning, health events, and the impact
diseases and treatments have on the lives of patients
and their families. The methods used to record and pro-
cess that information has evolved over time so that
today regulators require that trials use rigorous methods
for all subjective assessments employed to evaluate
treatments. This presentation is a brief review of the
past, current, and future direction of PRO research and
its implication for clinical trial measurement from the
perspective of a PRO researcher working in medical
product development trials.
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